Veranova: A CDMO that manages complexity with confidence.
01 1Veranova, L.P.
02 1Amino Chemicals Ltd
03 1Apicore Pharmaceuticals Private Limited
04 1Apothecon Pharmaceuticals Pvt Ltd
05 2Dipharma Francis S.r.l.
06 1Lonza AG
01 3MIGLUSTAT
02 3Miglustat
03 1Miglustat Milled
01 2India
02 2Italy
03 1Malta
04 2U.S.A
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 50137-4237
Start Marketing Date : 2014-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
NDC Package Code : 66005-0045
Start Marketing Date : 2015-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-166
Start Marketing Date : 2011-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76339-178
Start Marketing Date : 2021-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (9.999kg/9.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0671
Start Marketing Date : 2024-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0665
Start Marketing Date : 2024-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0827
Start Marketing Date : 2003-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
92
PharmaCompass offers a list of Miglustat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Miglustat manufacturer or Miglustat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Miglustat manufacturer or Miglustat supplier.
PharmaCompass also assists you with knowing the Miglustat API Price utilized in the formulation of products. Miglustat API Price is not always fixed or binding as the Miglustat Price is obtained through a variety of data sources. The Miglustat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zavesca (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zavesca (TN), including repackagers and relabelers. The FDA regulates Zavesca (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zavesca (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zavesca (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zavesca (TN) supplier is an individual or a company that provides Zavesca (TN) active pharmaceutical ingredient (API) or Zavesca (TN) finished formulations upon request. The Zavesca (TN) suppliers may include Zavesca (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Zavesca (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zavesca (TN) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zavesca (TN) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zavesca (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zavesca (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zavesca (TN) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zavesca (TN) suppliers with NDC on PharmaCompass.
We have 6 companies offering Zavesca (TN)
Get in contact with the supplier of your choice:
